Preventing Urinary Tract Infections

Because UTIs are a universal health problem and since antibiotic resistance is increasing at an uncontrolled rate, vaccines are currently being developed to treat this infection. The clinical trial of the first vaccine, SolcoUrovac, has shown promise in women with recurrent UTIs. However, more long term follow up is required to document any side effects or complications. Unlike vaccines in children, this vaccine is administered as a vaginal suppository. Other research is being conducted on potential vaccines that can prevent the attachment of the bacteria to the lining of the bladder. Read More »